Share. Connect. Create. Grow. · Socialiya
Why This Biotech Stock, With Its First FDA Approval, Just Crashed By Double Digits

Celcuity stock crashed Wednesday after the biotech delayed the launch of its just-approved breast ca...

BUSINESS NEWS July 15, 2026

Why This Biotech Stock, With Its First FDA Approval, Just Crashed By Double Digits

Celcuity stock crashed Wednesday after the biotech delayed the launch of its just-approved breast cancer treatment until the third quarter.

6 views 0 likes 0 comments
Share:
Celcuity stock crashed Wednesday after the biotech delayed the launch of its just-approved breast cancer treatment until the third quarter.

Author: Investor's Business Daily

Read Original Article

Related News

Advertisement
socialiya
Advertisement

Top Categories

Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya